A recent article in the journal Nature describes some interesting new discoveries that have been made about the role of the hormone progesterone in hormone receptor-positive breast cancer.
The role of progesterone and its receptor in breast cancer has not been well understood. And there has been some controversy about the value of this biomarker in selecting treatment for patients.
The study results, if confirmed, could potentially lead to improved treatment options for women with this common sub-type of breast cancer. Continue reading